Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2018; 8(6): 175-177


PRESCRIBING PATTERN OF GLICLAZIDE, METFORMIN AND COMBINATION THERAPY WITH INSULIN IN UAE

Sabrina Ait Gacem, Zainab Tehami, Maryam Mazrouai, Mohamed Shamssain.




Abstract

Diabetes Mellitus (DM) is characterized by the inability of the body to process sugar. Glycemic control is important in the management of diabetic patients therefore there is a particular concern towards the insufficient management of oral drug therapy and delayed insulin therapy initiation. The current study was made to observe the status of anti-diabetic drugs’ prescription pattern. This is a cross-sectional, questionnaire based survey study, which was conducted over a period of February 2014 to May 2014 and it was carried out in Ajman. A convenient sample comprising a total of (213) diabetic participants 18 years old and above. A self-administered bilingual questionnaire was used as a tool to collect data and the results were analyzed using Microsoft Excel. The prescribing trend was found to be monotherapy (43%Metformin, 33% Insulin and 17% Gliclazide) and (7%) of participants used a combination therapy of Metformin and Insulin. The study reflected that the prescribing trend in the enrolled participants was mainly monotherapy and among the cardiovascular complications reported that can cause major threat was hypertension.Similar other studies indicate that the compliance to medication, exercise and avoiding risk factors are very important to prevent complications.

Key words: Diabetes mellitus, Insulin, Metformin, Gliclazide






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.